Works matching IS 10837159 AND DT 2019 AND VI 24
Results: 415
Chemotherapy Toxicity in BRCA Mutation Carriers Undergoing First‐Line Platinum‐Based Chemotherapy.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1471, doi. 10.1634/theoncologist.2019-0272
- By:
- Publication type:
- Article
Acknowldegment.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1519, doi. 10.1634/theoncologist.2019-r000
- Publication type:
- Article
Volume 24 Author Index.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1496, doi. 10.1634/theoncologist.2019-a000
- Publication type:
- Article
Identifying Barriers and Facilitators to Breast Cancer Early Detection and Subsequent Treatment Engagement in Kenya: A Qualitative Approach.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1549, doi. 10.1634/theoncologist.2019-0257
- By:
- Publication type:
- Article
Outcomes in Patients Treated with Laser Interstitial Thermal Therapy for Primary Brain Cancer and Brain Metastases.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1467, doi. 10.1634/theoncologist.2019-0213
- By:
- Publication type:
- Article
Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1562, doi. 10.1634/theoncologist.2018-0054
- By:
- Publication type:
- Article
Development and Validation of an Easy‐to‐Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1321, doi. 10.1634/theoncologist.2019-0058
- By:
- Publication type:
- Article
An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1294, doi. 10.1634/theoncologist.2019-0236
- By:
- Publication type:
- Article
Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy‐Refractory Testicular Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1437, doi. 10.1634/theoncologist.2019-0295
- By:
- Publication type:
- Article
A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1512, doi. 10.1634/theoncologist.2019-0516
- By:
- Publication type:
- Article
A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1510, doi. 10.1634/theoncologist.2019-0514
- By:
- Publication type:
- Article
Meta‐Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1315, doi. 10.1634/theoncologist.2018-0675
- By:
- Publication type:
- Article
Pathological Response to Neoadjuvant Chemotherapy and the Molecular Classification of Locally Advanced Breast Cancer in a Latin American Cohort.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1360, doi. 10.1634/theoncologist.2019-0300
- By:
- Publication type:
- Article
Pan‐Cancer Analysis of CDK12 Loss‐of‐Function Alterations and Their Association with the Focal Tandem‐Duplicator Phenotype.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1526, doi. 10.1634/theoncologist.2019-0214
- By:
- Publication type:
- Article
Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1286, doi. 10.1634/theoncologist.2019-0124
- By:
- Publication type:
- Article
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen‐Activated Protein Kinase Pathway Alterations.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1584, doi. 10.1634/theoncologist.2019-0223
- By:
- Publication type:
- Article
Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1351, doi. 10.1634/theoncologist.2019-0166
- By:
- Publication type:
- Article
Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1534, doi. 10.1634/theoncologist.2019-0171
- By:
- Publication type:
- Article
<sup>18</sup>F‐FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor‐Positive Breast Cancer: A Retrospective Comparative Study with <sup>18</sup>F‐FDG PET/CT.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1277, doi. 10.1634/theoncologist.2019-0096
- By:
- Publication type:
- Article
A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High‐Risk Subtypes?
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1381, doi. 10.1634/theoncologist.2019-0113
- By:
- Publication type:
- Article
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1417, doi. 10.1634/theoncologist.2019-0152
- By:
- Publication type:
- Article
Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1443, doi. 10.1634/theoncologist.2019-0009
- By:
- Publication type:
- Article
Postintervention Interleukin‐6 (IL‐6) Level, Rather than the Pretreatment or Dynamic Changes of IL‐6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1489, doi. 10.1634/theoncologist.2018-0669
- By:
- Publication type:
- Article
Delays and Barriers to Cancer Care in Low‐ and Middle‐Income Countries: A Systematic Review.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1371, doi. 10.1634/theoncologist.2019-0057
- By:
- Publication type:
- Article
Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid Cancers.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1303, doi. 10.1634/theoncologist.2018-0845
- By:
- Publication type:
- Article
Integration of Tumor‐Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1426, doi. 10.1634/theoncologist.2017-0603
- By:
- Publication type:
- Article
Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1268, doi. 10.1634/theoncologist.2019-0167
- By:
- Publication type:
- Article
Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG‐PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1460, doi. 10.1634/theoncologist.2018-0882
- By:
- Publication type:
- Article
One‐Day Versus Three‐Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy‐Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data‐Based Meta‐Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1593, doi. 10.1634/theoncologist.2019-0133
- By:
- Publication type:
- Article
POETIC (Program for Enhanced Training in Cancer): An Initial Experience of Supporting Capacity Building for Oncology Training in Sub‐Saharan Africa.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1557, doi. 10.1634/theoncologist.2019-0207
- By:
- Publication type:
- Article
Secondary Use of Patient Tissue in Cancer Biobanks.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1577, doi. 10.1634/theoncologist.2018-0376
- By:
- Publication type:
- Article
Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1388, doi. 10.1634/theoncologist.2019-0063
- By:
- Publication type:
- Article
Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next‐Generation Sequencing‐Based Multiplex Gene Panel Assay.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1401, doi. 10.1634/theoncologist.2018-0587
- By:
- Publication type:
- Article
Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor‐Mutant Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1570, doi. 10.1634/theoncologist.2019-0158
- By:
- Publication type:
- Article
Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1514, doi. 10.1634/theoncologist.2019-0019
- By:
- Publication type:
- Article
Characteristics of BRAF<sup>V600E</sup> Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1331, doi. 10.1634/theoncologist.2018-0914
- By:
- Publication type:
- Article
Dancing with Deterrents: Understanding the Role of Abuse‐Deterrent Opioid Formulations and Naloxone in Managing Cancer Pain.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1505, doi. 10.1634/theoncologist.2019-0340
- By:
- Publication type:
- Article
An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large‐Scale, Multicenter Study.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1476, doi. 10.1634/theoncologist.2018-0868
- By:
- Publication type:
- Article
The Development of an International Oncofertility Competency Framework: A Model to Increase Oncofertility Implementation.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1450, doi. 10.1634/theoncologist.2019-0043
- By:
- Publication type:
- Article
Long‐Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1543, doi. 10.1634/theoncologist.2018-0786
- By:
- Publication type:
- Article
A Randomized, Double‐Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX‐427) in Patients with Previously Untreated Stage IV Non‐Squamous‐Non‐Small‐Cell Lung Cancer: The SPRUCE Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1409, doi. 10.1634/theoncologist.2018-0518
- By:
- Publication type:
- Article
Long‐Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High‐Risk Bladder Cancer (Ta, Tis, T1, T2).
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1341, doi. 10.1634/theoncologist.2018-0280
- By:
- Publication type:
- Article
Pediatric NUT Carcinoma Is a Rare and Challenging Tumor: Single Center Experience of Five Children.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1232, doi. 10.1634/theoncologist.2019-0358
- By:
- Publication type:
- Article
Contemporary Outcomes for Advanced‐Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1488, doi. 10.1634/theoncologist.2019-0172
- By:
- Publication type:
- Article
1q21 Gain Combined with High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1132, doi. 10.1634/theoncologist.2019-0132
- By:
- Publication type:
- Article
Miles and Memories.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1502, doi. 10.1634/theoncologist.2019-0586
- By:
- Publication type:
- Article
Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1497, doi. 10.1634/theoncologist.2019-0316
- By:
- Publication type:
- Article
Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD‐1/PDL‐1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1416, doi. 10.1634/theoncologist.2018-0686
- By:
- Publication type:
- Article
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1228, doi. 10.1634/theoncologist.2019-0250
- By:
- Publication type:
- Article
Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1420, doi. 10.1634/theoncologist.2019-0513
- By:
- Publication type:
- Article